CLIQX | VEVYX | CLIQX / VEVYX | |
Total Expense Ratio | 0.82 | 0.66 | 124% |
Annual Report Gross Expense Ratio | 1.08 | 0.66 | 164% |
Fund Existence | 6 years | 12 years | - |
Gain YTD | -1.479 | -2.585 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 121M | 17.2B | 1% |
Annual Yield % from dividends | 2.90 | 1.12 | 258% |
Returns for 1 year | 11.36 | -8.17 | -139% |
Returns for 3 years | 12.80 | -4.45 | -287% |
Returns for 5 years | 61.47 | 34.41 | 179% |
Returns for 10 years | N/A | 42.68 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SBIO | 30.07 | 0.94 | +3.24% |
ALPS Medical Breakthroughs ETF | |||
AVES | 51.12 | 0.31 | +0.61% |
Avantis Emerging Markets Value ETF | |||
PUTW | 30.15 | N/A | N/A |
WisdomTree PutWrite Strategy Fund | |||
BSCQ | 19.49 | -0.01 | -0.05% |
Invesco BulletShares 2026 Corp Bd ETF | |||
MBNE | 28.54 | -0.06 | -0.20% |
SPDR® Nuveen Municipal Bond ESG ETF |